Gallbladder Disease and GLP-1 Medication Safety Patients with pre-existing gallbladder disease face higher risk when starting semaglutide because inflammation, stones, or scar tissue already compromise biliary function
The structural reason: patients who stop semaglutide regain weight, so the healthcare-savings channel only delivers if treatment continues
The normalized TR-FRET signals were plotted against the compound concentrations on a logarithmic scale
Role of indoxyl sulfate in CKD-associated vascular inflammation Although CKD patients commonly have CVD risk factors (e.g., hypertension, dyslipidemia, diabetes), such traditional factors cannot entirely explain their increased cardiovascular risk ( , , , , )
Never ignore the urge to defecate, as delaying can worsen constipation
(Science, IF=56.9) 6 28